PMA supplement

P040024 S006: PERLANE INJECTABLE GEL

FDA PMA supplement · Panel Track · Q-Med AB

Key facts

Original PMA P040024
Supplement number S006
Supplement type Panel Track
Reason for the supplement Labeling Change - Indications/instructions/shelf life/tradename
Trade name PERLANE INJECTABLE GEL
Generic name Implant, dermal, for aesthetic use
Applicant Q-Med AB
Product code LMH
Received date Mar 28, 2006
Decision date May 2, 2007
Docket number 07M-0180
Notice date May 11, 2007

At a glance

  • No Expedited review granted
  • Yes Approval order on file
  • Yes Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements